Efficacy of Bevacizumab and Gemcitabine in Combination with Cisplatin in the Treatment of Esophageal Cancer and the Effect on the Incidence of Adverse Reactions

OBJECTIVE: To evaluate the efficacy of bevacizumab and gemcitabine in combination with cisplatin in the treatment of esophageal cancer and the effect on the incidence of adverse reactions. METHODS: A total of 100 esophageal cancer patients admitted to our hospital from March 2019 to March 2021 were...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jiangfeng, Zhao, Qiang, Cai, Lei, Li, Jianqiang, Chen, Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038406/
https://www.ncbi.nlm.nih.gov/pubmed/35480138
http://dx.doi.org/10.1155/2022/2317181

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9038406/
https://www.ncbi.nlm.nih.gov/pubmed/35480138
http://dx.doi.org/10.1155/2022/2317181

Ejemplares similares